首页> 外文期刊>Investigational new drugs. >Modified ingenol semi-synthetic derivatives from Euphorbia tirucalli induce cytotoxicity on a large panel of human cancer cell lines
【24h】

Modified ingenol semi-synthetic derivatives from Euphorbia tirucalli induce cytotoxicity on a large panel of human cancer cell lines

机译:从大戟替氏肌肤的改性ingenol半合成衍生物在大型人类癌细胞系中诱导细胞毒性

获取原文
获取原文并翻译 | 示例
           

摘要

The latex from Euphorbia tirucalli is used in Brazil as a folk medicine for several diseases, including cancer. Recently, we showed a cytotoxic activity of E. tirucalli euphol in a wide range of cancer cell lines. Moreover, we showed that euphol inhibits proliferation, motility and colony formation in pancreatic cancer cells, induces autophagy and sensitizes glioblastoma cells to temozolomide cytotoxicity. Herein, we report in vitro activity of three semi-synthetic ingenol compounds derived from E. tirucalli, IngA (ingenol-3-trans-cinnamate), IngB (ingenol-3-hexanoate) and IngC (ingenol-3-dodecanoate), against a large panel of human cancer cell lines. Antineoplastic effects of the three semi-synthetic compounds were assessed using MTS assays on 70 cancer cell lines from a wide array of solid tumors. Additionally, their antitumor potential was compared with known compounds of the same class, namely ingenol-3-angelate (Picato?) and ingenol 3,20-dibenzoate and in combination with standard chemotherapeutic agents. We observed that IngA, B, and C exhibited dose-dependent cytotoxic effects. Amongst the semi-synthetic compounds, IngC displayed the best activity across the tumor cell lines. In comparison with ingenol-3-angelate and ingenol 3,20-dibenzoate, IngC showed a mean of 6.6 and 3.6-fold higher efficacy, respectively, against esophageal cancer cell lines. Besides, IngC sensitized esophageal cancer cells to paclitaxel treatment. In conclusion, the semi-synthetic ingenol compounds, in particular, IngC, demonstrated a potent antitumor activity on all cancer cell lines evaluated. Although the underlying mechanisms of action of IngC are not elucidated, our results provide insights for further studies suggesting IngC as a putative therapy for cancer treatment.
机译:来自大戟属Tirucalli的乳胶用于巴西作为一种民间医学,用于几种疾病,包括癌症。最近,我们在广泛的癌细胞系中显示了E. Tirucalli昆育的细胞毒性活性。此外,我们表明昆育毒性抑制胰腺癌细胞中的增殖,运动和菌落形成,诱导自噬并敏感胶质母细胞瘤细胞毒性。在此,我们报告了来自E.Tirucalli,Inga(Ingenol-3-反式肉桂酸酯),INGB(Ingenol-3-己酸酯)和Ingc(Ingenol-3-十二烷酸酯)的三种半合成的ingenol化合物的体外活性。一个大型人类癌细胞系。使用来自各种固体瘤的70个癌细胞系的MTS测定评估三种半合成化合物的抗肿瘤效果。另外,将它们的抗肿瘤电位与相同类的已知化合物进行比较,即Ingenol-3-帝理(PICATOγ)和ingenol 3,20-二苯甲酸盐并与标准化学治疗剂组合。我们观察到Inga,B和C表现出剂量依赖性细胞毒性效应。在半合成化合物中,INGC显示肿瘤细胞系的最佳活动。与Ingenol-3-天使和Ingenol 3,20-二苯甲酸盐相比,INGC分别显示出对食管癌细胞系的6.6%和3.6倍的效率。此外,Ingc致敏感食管癌细胞对紫杉醇治疗。总之,半合成的ingenol化合物,特别是Ingc,在评估的所有癌细胞系上表现出有效的抗肿瘤活性。虽然INGC的潜在行动机制并不阐明,但我们的结果提供了进一步研究的见解,表明INGC作为癌症治疗的推定疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号